1. Home
  2. Personal Injury and Tort
  3. First Neurontin trial begins 

First Neurontin trial begins (access required)
Plaintiffs’ lawyer attacks off-label marketing

By Nora Lockwood Tooher
Staff writer
Published: July 29, 2009

Tags:

BOSTON - Addressing jurors in the first Neurontin suicide trial, plaintiffs' lawyer Mark Lanier asserted that drug maker Pfizer knew the anti-epilepsy medication increased the risk of suicide, but intentionally marketed off-label uses to boost the drug's sales. Lanier, a well-known Houston attorney, is representing the family of Susan Bulger, a 39-year-old Peabody, Mass. woman who ...
© Copyright 2010 Lawyers USA. All Rights Reserved.


Comments

You must be logged in to post comments.

FREE White Papers

Most Viewed Stories

  1. The ‘cocktail party' of social media marketing
  2. Ten tips for better staff evaluations
  3. Immigration lawyer finds early gamble on Internet marketing pays off
  4. Supreme Court case could eviscerate consumer class actions
  5. Understanding the real cost of technology

Stay Connected with Lawyers USA

Lawyers USA keeps you connected with all the latest news affecting you and your practice with Daily, Practice and Breaking News alerts.

To Sign-up or Manage your Alerts, click here.

Feeds/Web 2.0:

LEGAL BLOGS

DC Dicta Legal buzz from WashingtonDC Dicta Legal buzz from Washington

Benchmarks Recent decisions and analysis

Blog Roll

FEATURED PODCAST

Think Twitter's for kids? Think again.

 

Some might think Twitter is a gimmick for young lawyers and associates to get their names out there. In a conference call, attorney and social media consultant Adrian Dayton spoke with Bob White, a partner-level attorney in Florida on how he has Tweeted his way to new clients.

Click here to listen to the podcast.

Click here for the Podcast archive.